CXCL8 and gastric cancer: Thus, our data indicate that the tumor-promoting effect of GC-MSCs is partly blocked by IL-8-specific neutralizing antibody, which suggests a critical role of IL-8 in gastric caner progression mediated by GC-MSCs.